Buying a high-quality growth company at peak valuations just as growth decelerates — producing poor returns even without any fundamental collapse in the business.
“The stock of an outstanding company purchased at a foolish price is not an outstanding investment. The greatness of the company and the attractiveness of the investment are entirely different judgments, and they must be made independently. — Philip Fisher”
— Philip Fisher
Deeper Explanation
The growth trap is one of the most common and most expensive mistakes in growth investing. It arises from the intersection of two forces acting simultaneously: earnings growth slows from its peak rate (which may still be healthy in absolute terms), and the premium valuation multiple that priced in sustained high growth compresses sharply. The result is a double compression — lower earnings estimates multiplied by a lower multiple — that can produce 30–50% stock price declines in companies whose businesses remain fundamentally sound. The five primary causes of growth traps are market saturation (the TAM is smaller or slower to develop than believed), competitive disruption (a new entrant or technology erodes the moat), margin normalisation (high margins were temporary rather than structural), management over-expansion into adjacent markets where competitive advantages do not transfer, and valuation compression even if growth continues at a reduced pace. The earliest warning signals are decelerating new customer additions, rising churn, and management language shifting from expansion to cost management.
Continue Learning
Go deeper into the Growth school — frameworks, case studies, and decision systems.